Citadel Advisors
EXAS

Citadel Advisors’s Exact Sciences EXAS Stock Holding History

Citadel Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-193,500
Closed -$19.7M – 13313
2025
Q4 		$19.7M Sell
193,500
-900
-0.5% -$72.3K ﹤0.01% 2367
2025
Q3 		$10.6M Buy
194,400
+91,300
+89% +$4.56M ﹤0.01% 3181
2025
Q2 		$5.48M Sell
103,100
-60,700
-37% -$3.08M ﹤0.01% 3946
2025
Q1 		$7.09M Sell
163,800
-78,200
-32% -$3.96M ﹤0.01% 3349
2024
Q4 		$13.6M Sell
242,000
-36,700
-13% -$2.28M ﹤0.01% 2595
2024
Q3 		$19M Buy
278,700
+42,100
+18% +$2.38M ﹤0.01% 2103
2024
Q2 		$10M Buy
236,600
+126,700
+115% +$6.97M ﹤0.01% 2772
2024
Q1 		$7.59M Buy
109,900
+5,000
+5% +$316K ﹤0.01% 3329
2023
Q4 		$7.76M Buy
104,900
+28,600
+37% +$1.87M ﹤0.01% 3173
2023
Q3 		$5.21M Sell
76,300
-20,800
-21% -$1.76M ﹤0.01% 3584
2023
Q2 		$9.12M Buy
97,100
+14,500
+18% +$1.13M ﹤0.01% 2796
2023
Q1 		$5.6M Sell
82,600
-173,900
-68% -$11.2M ﹤0.01% 3615
2022
Q4 		$12.7M Buy
256,500
+17,300
+7% +$707K ﹤0.01% 2495
2022
Q3 		$7.77M Buy
239,200
+27,700
+13% +$1.14M ﹤0.01% 3133
2022
Q2 		$8.33M Sell
211,500
-105,900
-33% -$5.66M ﹤0.01% 2925
2022
Q1 		$22.2M Sell
317,400
-53,500
-14% -$3.91M ﹤0.01% 1866
2021
Q4 		$28.9M Sell
370,900
-9,600
-3% -$847K 0.01% 1637
2021
Q3 		$36.3M Sell
380,500
-20,500
-5% -$2.16M 0.01% 1383
2021
Q2 		$49.8M Buy
401,000
+85,900
+27% +$10.3M 0.01% 1131
2021
Q1 		$41.5M Buy
315,100
+69,700
+28% +$9.54M 0.01% 1208
2020
Q4 		$32.5M Sell
245,400
-29,200
-11% -$3.53M 0.01% 1319
2020
Q3 		$28M Buy
274,600
+61,300
+29% +$5.29M 0.01% 1286
2020
Q2 		$18.5M Sell
213,300
-51,400
-19% -$4.11M 0.01% 1571
2020
Q1 		$15.4M Sell
264,700
-82,100
-24% -$6.67M 0.01% 1457
2019
Q4 		$32.1M Sell
346,800
-21,400
-6% -$1.88M 0.01% 1072
2019
Q3 		$33.3M Buy
368,200
+92,100
+33% +$10.5M 0.02% 1044
2019
Q2 		$32.6M Buy
276,100
+17,700
+7% +$1.78M 0.01% 1010
2019
Q1 		$22.4M Sell
258,400
-91,800
-26% -$7.81M 0.01% 1239
2018
Q4 		$22.1M Sell
350,200
-22,400
-6% -$1.54M 0.01% 1150
2018
Q3 		$29.4M Buy
372,600
+101,900
+38% +$6.64M 0.01% 1095
2018
Q2 		$16.2M Buy
270,700
+22,400
+9% +$1.21M 0.01% 1493
2018
Q1 		$10M Sell
248,300
-57,500
-19% -$2.8M 0.01% 1729
2017
Q4 		$16.1M Buy
305,800
+74,700
+32% +$3.99M 0.01% 1315
2017
Q3 		$10.9M Buy
231,100
+75,600
+49% +$3.04M 0.01% 1528
2017
Q2 		$5.5M Buy
155,500
+50,200
+48% +$1.55M ﹤0.01% 2026
2017
Q1 		$2.49M Sell
105,300
-49,300
-32% -$977K ﹤0.01% 2811
2016
Q4 		$2.06M Buy
154,600
+19,400
+14% +$313K ﹤0.01% 2912
2016
Q3 		$2.51M Buy
135,200
+40,200
+42% +$708K ﹤0.01% 2702
2016
Q2 		$1.16M Buy
95,000
+43,400
+84% +$327K ﹤0.01% 3383
2016
Q1 		$348K Sell
51,600
-4,600
-8% -$29.4K ﹤0.01% 4898
2015
Q4 		$519K Sell
56,200
-12,400
-18% -$115K ﹤0.01% 4422
2015
Q3 		$1.23M Sell
68,600
-22,700
-25% -$521K ﹤0.01% 3544
2015
Q2 		$2.71M Sell
91,300
-1,600
-2% -$40.2K ﹤0.01% 2695
2015
Q1 		$2.05M Buy
92,900
+50,600
+120% +$1.28M ﹤0.01% 3031
2014
Q4 		$1.16M Sell
42,300
-5,500
-12% -$134K ﹤0.01% 3584
2014
Q3 		$926K Buy
47,800
+22,900
+92% +$420K ﹤0.01% 3794
2014
Q2 		$424K Sell
24,900
-9,100
-27% -$125K ﹤0.01% 4616
2014
Q1 		$482K Sell
34,000
-18,300
-35% -$247K ﹤0.01% 4387
2013
Q4 		$611K Buy
52,300
+6,100
+13% +$70K ﹤0.01% 3769
2013
Q3 		$546K Sell
46,200
-900
-2% -$11.5K ﹤0.01% 3711
2013
Q2 		$655K Buy
+47,100
New +$512K ﹤0.01% 3580

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Citadel Advisors's EXAS Position: Q1 2026 in Review

Citadel Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 83,025 shares — an estimated $8.43M sold.

Citadel Advisors first reported a position in EXAS in Q2 2013 and held it in 48 quarters. The position peaked at $229M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Citadel Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 83,025 Exact Sciences shares in Q1 2026, an estimated $8.43M.
  • Citadel Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 48 quarters.
  • Citadel Advisors's Exact Sciences position peaked at $229M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.